EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION

Not authorised

Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Canine adenovirus 2, strain DK13, Live
Canine distemper virus, strain BA5, Live
Canine parvovirus, strain CAG2, Live
Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated

Product identification

Medicine name:

Active substance:

Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Canine adenovirus 2, strain DK13, Live
Canine distemper virus, strain BA5, Live
Canine parvovirus, strain CAG2, Live
Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated

Target species:

Route of administration:

Active substance and strength:

Pharmaceutical form:

Anatomical therapeutic chemical veterinary (ATCvet) codes:

Legal status of supply:

Authorisation status:

Authorised in:

Package description:

Plastic box of 25 vials (glass) of lyophilisate (1 dose) and 25 vials (glass) of suspension (1 ml)
Plastic box of 50 vials (glass) of lyophilisate (1 dose) and 50 vials (glass) of suspension (1 ml)
Plastic box of 10 vials (glass) of lyophilisate (1 dose) and 10 vials (glass) of suspension (1 ml)

Entitlement type:

Legal basis of product authorisation:

Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)

Marketing authorisation holder:

Marketing authorisation date:

Manufacturing sites for batch release:

Responsible authority:

Authorisation number:

Date of authorisation status change:

Reference member state:

Procedure number:

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet